Evidence map›Paper›PMID 28445558›Full record

Observational studyJAMA dermatology2017

Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.

Michelle A Bongiorno, Neera Nathan, Oyetewa Oyerinde, Ji-An Wang, Chyi-Chia Richard Lee, G Thomas Brown, Joel Moss, Thomas N Darling

Abstract readObservational Study
In one paragraph

Observational study in JAMA dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Mysterious Black Plaque in a Patient of Tuberous Sclerosis.Indian dermatology online journal · 2026
    Article
  2. Tuberous sclerosis complex.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Article
  5. [Syndroms associated with benign skin tumors].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2022
    Review
  6. Review
  7. Article
  8. Miliary fibromas in tuberous sclerosis complex.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  9. Article
  10. Hereditary Syndromes in Neuroendocrine Tumors.Current treatment options in oncology · 2020
    Review
  11. Article
  12. Fibrous cephalic plaques in tuberous sclerosis complex.Journal of the American Academy of Dermatology · 2018
    Article
  13. Animals in Dermatology.Indian journal of dermatology
    Article
  14. Article
  15. Article
  16. Collagenoma of the Eyelid.Ophthalmic plastic and reconstructive surgery
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Michelle A BongiornoDepartment of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland2Naval Health Clinic, Pearl Harbor, Hawaii.
Neera NathanDepartment of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland3Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland4Department of Medicine, Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio.
Oyetewa OyerindeDepartment of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland3Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Ji-An WangDepartment of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Chyi-Chia Richard LeeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
G Thomas BrownLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland6Lister Hill National Center for Biomedical Communications, US National Library of Medicine, Bethesda, Maryland.
Joel MossCardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Thomas N DarlingDepartment of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Uniformed Services University of the Health Sciences · USCenter for Cancer Research · USNational Center for Biotechnology Information · USNational Heart Lung and Blood Institute · USNational Institutes of Health · US

Funding

Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)ZIAHL002541 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MOSS, JOEL · 2009 to 2025
$47.7M
Regulation of Dermal Fibroblasts in Skin Regeneration and HealingR01AR062080 · NIAMS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI DARLING, THOMAS N · 2012 to 2016
$1.7M
NIAMS NIH HHS R01 AR062080
6 · The paper itself

Abstract

Importance: Patients with tuberous sclerosis complex (TSC) frequently develop collagenous connective tissue nevi. The prototypical lesion is a large shagreen patch located on the lower back, but some patients only manifest small collagenomas or have lesions elsewhere on the body. The ability to recognize these variable presentations can be important for the diagnosis of TSC. Objective: To describe the clinical characteristics of connective tissue nevi on the trunk and extremities of patients with tuberous sclerosis complex. Design, Setting, and Participants: A retrospective analysis of patient medical records and skin photography was performed; 104 adult patients with TSC were enrolled in an observational cohort study that was enriched for those with pulmonary lymphangioleiomyomatosis, and was therefore composed mostly of women (99 women, 5 men). All patients included were examined at the National Institutes of Health (NIH) in Bethesda, Maryland, from 1998 to 2013. Connective tissue nevi were categorized per anatomic location and size. Lesions less than 1 cm in diameter were termed collagenomas. Shagreen patches were characterized as small (1 to <4 cm), medium (4 to <8 cm), and large (≥8 cm). Main Outcome and Measures: Frequency, anatomic location, size, and histological appearance of connective tissue nevi in patients with TSC. Results: Overall, 58 of 104 patients (median [range] age, 42 [19-70] years) with TSC (56%) had at least 1 connective tissue nevus on the trunk or thighs; of these, 28 of 58 patients (48%) had a solitary lesion, and 30 of 58 patients (52%) had 2 or more lesions. Overall, 120 lesions from 55 patients were classified by size; 46 lesions (38%) were collagenomas; 39 lesions (32%) were small shagreen patches; 21 lesions (18%), medium shagreen patches; and 14 lesions (12%), large shagreen patches. The distribution of lesions was 9% (n = 11), upper back; 29% (n = 35), middle back; 51% (n = 61), lower back; and 11% (n = 13), other locations. All 26 shagreen patches that were analyzed histopathologically had coarse collagen fibers and 24 of 26 stained with Miller elastic stain had decreased elastic fibers. On immunoblot analysis, fibroblasts grown from shagreen patches expressed higher levels of phosphorylated ribosomal protein S6 than paired fibroblasts from normal-appearing skin. Conclusions and Relevance: Tuberous sclerosis complex-related connective tissue nevi are not limited to the lower back, and occasionally present on the central or upper back, buttocks, or thighs. Elastic fibers are typically decreased. Recognition of these variable presentations can be important for TSC diagnosis.

Indexed as

AdultAgedCohort StudiesFemaleHumansMaleMiddle AgedNevusPhosphorylationRetrospective StudiesRibosomal Protein S6Tuberous SclerosisYoung AdultRibosomal Protein S6

Identifiers

PMID28445558
PMCPMC5817464
OpenAlexW2608927160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.